While the drug was well tolerated with no new safety concerns, the drug yielded no positive treatment benefits in a study even at its highest dose of 40 mg.
Oracle (NYSE: ORCL) finds itself at the epicenter of a significant credit controversy, sending ripples of unease through investor circles and casting a shadow over its aggressive artificial intelligence (AI) expansion strategy. The immediate catalyst for this intensified scrutiny, particularly around December 17, 2025, was a widely reported, though denied,
The financial markets are currently grappling with a significant downturn, primarily fueled by a sharp decline in chip stocks, which have consequently dragged the broader technology sector and overall market lower. This widespread sell-off, observed prominently in mid-December 2025, stems from a confluence of factors including mounting concerns over potentially
The Federal Reserve, in its December 2025 Federal Open Market Committee (FOMC) meeting, has once again adjusted its monetary policy, enacting a third consecutive interest rate cut to a new target range of 3.50%–3.75%. This decisive move underscores the central bank's commitment to navigating a complex economic
On December 17, 2025, the Nasdaq Composite Index experienced a significant downturn, shedding 350 points, or 1.5%, and falling below several critical support levels. This latest slump marks a concerning divergence in the broader market, as the tech-heavy index struggles while the Dow Jones Industrial Average concurrently reaches new
The S&P 500 (INDEXSP: .INX) has entered a precarious four-day losing streak as of Wednesday, December 17, 2025, marking Wall Street's longest continuous decline in nearly a month. This downturn, which has seen the benchmark index shed 2.60% of its value, is primarily fueled by mounting concerns over
As late 2025 draws to a close, a significant recalibration is underway in global financial markets, with investors increasingly rotating capital away from the once-dominant Big Tech and Artificial Intelligence (AI) sectors. This strategic shift marks a departure from the tech-led rallies that have characterized much of the past decade,
The seemingly unstoppable ascent of Artificial Intelligence (AI) investments is facing its sternest test yet, as a confluence of factors, including escalating market volatility, a growing skepticism over tangible returns, and stark warnings from industry titans, suggests that the much-hyped AI bubble may be on the verge of a significant
Redwood City, CA – December 17, 2025 – Oracle Corporation (NYSE: ORCL) saw its stock tumble significantly today, continuing a recent downward trend, as investors grappled with mounting concerns over the ambitious funding requirements for its burgeoning Artificial Intelligence (AI) infrastructure. The tech giant, which has aggressively positioned itself as a key
The technology sector is currently navigating a turbulent period, marked by a significant and deepening selloff that is exerting immense pressure on the Nasdaq Composite. As of December 17, 2025, a confluence of escalating "AI bubble" fears, disappointing corporate earnings, a noticeable rotation of capital away from speculative growth stocks,
As December 17, 2025, draws to a close, Wall Street finds itself in the throes of a significant market-wide selloff, sending shockwaves across global financial markets. Major U.S. indices—the Dow Jones Industrial Average (DJIA), S&P 500, and Nasdaq Composite—have all experienced sharp declines, erasing substantial gains
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
The bitcoin price slid as one source of support looks shaky. Strategy bitcoin buys may slow as MSTR stock falls, or else its interest costs may jump. Here's why.
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down by -1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -1.93%. December E-mini S&P futures (ESZ25 )...
Strong operating results did not stop one fund from walking away entirely, raising questions about how much patience volatile healthcare names really command.
Office furniture manufacturer MillerKnoll (NASDAQ:MLKN) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.6% year on year to $955.2 million. On top of that, next quarter’s revenue guidance ($943 million at the midpoint) was surprisingly good and 3.7% above what analysts were expecting. Its non-GAAP profit of $0.43 per share was 7.5% above analysts’ consensus estimates.
